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Development of a Totally Implantable Artificial Heart
Saitama Medical School Type Total Artificial Heart: STAH
Hiroyuki Noda, Shunei Kyo, Ryozo Omoto1)
Department of Cardiovascular Surgery, Saitama Medical School Moroyama, Iruma-gun, Saitama 350-0495, Japan, 
1)Saitama Medical School Hospital
　A prototype of Saitama Medical School type Total Artificial Heart (STAH) was newly developed. STAH designing 
is to be installed totally inside the mediastinal cavity replacing the natural heart. Because of the sophisticated 
shape of the blood pump based on an anatomical view, as well as separation of the blood pump from the actuator, 
the whole system is resulted in good feasibility for anatomical fitting. The principle of drive mechanism is that 
two pusher plates eject the blood in the left and the right chambers of the blood pump alternately, by driving a 
simple cam with an electromechanical actuator. This prototype has proven to eject 4.6 L/min on a mock circulatory 
system. Although further ef forts will be necessary for a practical application, the STAH pump may have a 
possibility to be one of the most promising devices as a total artificial heart.
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Introduction
　Although heart - transplantation procedure is accepted 
as a common treatment of profound heart failure, lack 
of the donor heart has appeared to be one of major 
problems as well as immune -suppression therapy. 
Under this situation, an artificial heart, which is able 
to replace total pump function of the natural heart, is 
the only one practical answer at present for solving 
donor - shortage 1). Already some artificial hearts have 
been applied to the patients with profound heart failure 
and resulted in some successful results from the ‘60s, 
but are not still capable for common therapy 2 -4). Even 
now, in spite of many trials 5 -15), none of the artificial 
heart has yet achieved any practical success to give a 
healthy life to the patient. 
　We have been researching mechanical circulatory 
system as well as investigating a totally implantable 
ar tificial hear t according to the Saitama Medical 
School Artificial Heart Project for these twenty years. 
As one of the results of the project, a prototype of the 
Saitama Medical School type total artificial heart has 
been developed, currently named STAH, has a unique 
mechanism that allows good capacity for anatomical 
fitting and easy manufacturing. This paper describes 
STAH in its details, and discusses future possibility for 
clinical application.
1. Materials and Methods
1.1 Total concept of designing
　A whole system is divided into two major parts, the 
blood pump, and the driving unit. A blood pump part is 
consisted of a pump housing, a pair of diaphragm with 
pusher -plate, and a cam. Two spaces made by pump 
housing and each diaphragm are called left and right 
blood chambers working as the left and right pump 
reservoir, respectively. Inside the blood pump a cam 
system is incorporated between the pusher plates. One 
way rotational motion supplied from the driving unit is 
converted to linear action by the cam, giving alternate 
movement to the two diaphragms attached to the left 
and the right blood chamber cavities, respectively. 
Thus the blood is pushed out from the each blood 
chambers alternately. The pump housing, that means 
outer cell structure of the blood pump, is designed to 
simulate the natural heart shape being suitable for the 
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residual pericardial cavity with minimizing unpleased 
compression against the organ structures aside. 
　A driving unit consists of a connector, a connecting 
wire, a coupler, an actuator and controller and power 
supply. To allow easy implantation and good stability in 
the humane body, the connecting wire is made flexible 
by introducing a connector, flexible wire, and coupler. 
All of the components are to be installed inside the 
humane body. But since a leading aim of the STAH 
prototype is to prove the primary practicality of the 
system only, designing of the driving unit receives 
no restrictions for the anatomical and physiological 
fitting to the natural body. So a controller is able only to 
regulate the rotation ratio of the actuator and is located 
outside of the actuator. Electrical power is supplied from 
conventional AC power. In the final stage the source of 
power will be controlled by DC only. A whole system 
configuration is illustrated in Fig. 1. 
1.2. Principle of displacement of the diaphragm
　The rotating cam is placed center of the left and the 
right blood chambers, being sandwiched between the 
diaphragms of each chambers. When the cam starts to 
rotate from zero degree at the top of the hypothetical 
circle, the cam top starts to push one diaphragm surface 
gradually according to displacement of the cam head. 
The initial quarter rotation gives one systolic motion 
as of a natural heart. The next quarter rotation of the 
cam relief the pushing power against the diaphragm, 
that means diastolic phase of the blood chamber. Thus 
a half rotation of the cam gives one single systolic and 
diastolic cycle for the one blood chamber. Subsequently 
the cam starts to push the other diaphragm. Finally one 
cycle of cam rotation results in alternate linear motion 
of two diaphragms. 
　Fig. 2 shows schematic drawing to explain cam and 
diaphragm relationship at various rotation angles in one 
chamber. Thus the left and the right blood chambers 
are driven alternately. The alternate motion gives the 
filling time for one blood chamber as diastolic phase 
when the other ejects blood as systolic phase at the 
same time. The pusher -plates made from the aluminum 
metal attached to each diaphragm are introduced to 
accept the cam motion and to transfer the power against 
the soft diaphragms with stable condition. 
1.3. Blood chamber
　The blood chamber is designed small enough for easy 
installation in the pericardial space of the human body 
simulating the natural heart as possible. The width of 
the whole body is 76 mm, the height from the left atrial 
port end to top of the body is 95 mm, and the interval of 
each atrial port is 48 mm in center as described in Fig. 3.
The pump housing of the left and right blood chambers 
have dif ferent shapes because inlet and outlet port 
shape are modified as being fitted to anatomical location 
of the left atrium, the aorta, the right atrium, and the 
pulmonary artery. Main material used for fabrication 
of the blood chamber shell is industrial grade silicon 
(Shinetsu Chemical, Japan). Classical dipping method 
was employed using the metal mold based on the clay 
model certified in calf fitting study. The diaphragm 
was made also from the silicon by dipping method. 
An aluminum plate was attached to the diaphragm in 
a series of fabrication of the diaphragm at the same 
time. The inside of the silicon blood chamber received 
surface treatment with re - coating of the silicon over the 
Fig. 1. Basic concept of the STAH system. Each character 
in the figure.  indicate system parts as follows; a: left or 
right blood chamber, b: left or right diaphragm, c: left or 
right pusher plate, d: cam, e: pump housing, f: connector, g: 
connecting wire, h: coupler, I: actuator, j: controller and power 
supply. A unit of the blood pump is consisted from a to f, and 
a unit of driving unit is from g to j, respectively. A big blank 
arrow shows an ideal direction of cam rotation. 
Fig. 2. Schematic drawing of relationship between the cam 
and pump diaphragm at each angle of the cam. Angles are 
shown by each degree per 180 degrees.
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initial silicon layer, when the diaphragm was assembled 
to the chamber. This process gives seamless inner 
surface of the blood chamber.
　Four mechanical artificial valves (Medtronic Hall 
valve, 25 mm in diameter, Medtronic, U.S.A.) were 
installed to the inlet and outlet of each blood chamber, 
respectively. The capacity of the left and the right 
chamber volume in static condition were 60 and 55 ml, 
respectively.
1.4. Cam
　A cam is an assembled unit consisted of eight 
bearings and metal plate. Four pairs of the bearing were 
attached to the one side of metal plate (shown in Fig. 4), 
which is shaved to produce an adequate linear motion 
to the diaphragm of the blood pump. When the plate 
rotates, four pairs of bearings push the pusher plate in 
succession. The cam was fixed into a supporting frame 
made from epoxy - resin. 
　A supporting frame works not only to fix the cam 
but also to couple the left and right blood chambers 
at angle of twenty degrees. Angled placement of the 
left and right blood chambers allows shortening of the 
length between the left and right atrial port enough for 
optimal anatomical fitting. At the center of the bottom of 
the frame, the connector was implanted for insertion of 
connecting wire.
　Fig. 4 shows assembled cam into supporting frame, 
which was ready to be sandwiched by the left and the 
right blood chambers.
 1.5. Connecting wire, coupler, actuator, controller 
and power supply
　The connecting wire and coupler work as delivery 
of the rotational power from the actuator to the cam. A 
connector was screwed in to an Oldham coupler by the 
flexible connecting wire (6 mm in diameter), and was 
tunneled through a flexible tube made of aluminum.
　An actuator was consisted of commercially available 
planetar y gear and coreless DC ser vomotor, and 
taco generator (TORMAX TC -3264XXG 17W, 24V, 
Chibaprecision Co., Ltd, Japan). These par ts were 
assembled lineally and placed into cylindrical acrylic 
acid resin case as described in Fig. 5. Rotation was 
controlled by a controller and power supply, which 
was consisted of current control board and AC -DC 
conver ter.  Electrical power was supplied from 
conventional AC 100V electric power source. The 
driving unit allowed revolution change up to 150 rpm by 
changing current under unloaded condition. 
Fig. 3. Ideal measurement made on a design specification 
of the blood pump is shown. Practical margin of error is not 
considered which may appears in a course of fabrication. 
Characters in the figure indicate each pump sites as follows: 
AO: aortic port, LA: left atrial port, PA: pulmonary arterial 
port, RA: right atrial port, L: left blood chamber housing, R: 
right blood chamber housing, SF: supporting frame.
Fig. 4. A supporting frame and the assembled cam are 
shown in ready - to -go condition. Character “a” indicates 
bearings assembled into cam plate (b). Character “c” indicates 
supporting frame. 
Fig. 5. Mechanical configuration of the actuator. Planetary 
gear, DC servomotor, and taco generator are coupled in 
production process. Each height is 43, 67, and 34mm, 
respectively as shown in the figure. Planetary gear brings 
maximum diameter by 42mm. These units are installed into a 
cylindrical acrylic acid resin case with 2mm thickness.
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　Another type of DC servomotor (100W, 24V. TOYU 
TECHNICA Co., Ltd, Japan) was also prepared for 
back up. This motor provided stronger power to the 
system. This servomotor was consequentially employed 
because of power shortage. 
1.6. Assembly of the whole system
　The left and the right blood chamber were assembled 
with the suppor ting frame that incorporated the 
cam. For easy understanding of outer shape of pump 
housing, the artificial grafts were attached to the aortic 
and the pulmonary arterial ports, the suturing cuff, 
temporarily made from polyether -polyurethane, to the 
left and the right atrial ports, respectively, as shown in 
Fig. 6. For in - vitro study, solid tubes were inserted to 
the inlets and outlets instead of grafts and cuffs. 
　The blood pump, connecting wire and driving unit are 
finally assembled into one system as shown in Fig. 7. 
1.7.  Anatomical fitting study of the blood pump
　To examine anatomical fit in the chest cavity, chest 
cavity model supplied by Uyama et al., National 
Cardiovascular Center Research Institute, Japan,16) was 
employed.
1.8. In -vitro evaluation
　A simple over flow type mock circuit was employed 
to evaluate in - vitro pump function. As a simulation 
of the physiological systemic circulation against the 
left side of the blood pump, the mock circuit supplies 
variable afterload by changing height of the water level 
with 20 mmHg of fixed preload. As a simulation of the 
pulmonary circulation for the right side of the pump, 
40 mmHg as afterload and 20 mmHg as preload were 
fixed in the mock circuit, respectively. The circuit was 
filled up with tap water enough to supply the scheduled 
condition.
　Using the mock circuit, pump flow, arterial pressure, 
and motor current were constantly monitored. Since 
pump rate was controlled manually, accurate pump rate 
was calculated manually on the recorded paper after 
termination of the study.  
　Evaluation of the system was performed in two steps. 
The first step was performed to evaluate the primary 
whole system per formance. Based on the primar y 
result, the second step evaluation was done to find 
out pure blood pump performance using larger 100W 
DC -servomotor because the motor employed in the 
first step study was evaluated not enough to prove the 
actual performance of the blood pump.
2. Result
2.1. Potency for anatomical suitability
　The blood pump was easily installed into the 
pericardial space of the human chest cavity model. No 
unnatural folding of the left and right outlet conduits 
or mechanical pressure coming out from the blood 
pump body were observed toward the chest wall or the 
vertebral bones as seen in Fig. 8.
Fig. 6. Photograph of backside view of the assembled blood 
pump. Dacron grafts are attached to the aortic port (b) and 
the pulmonary arterial port (d) for easy understanding. A pair 
of atrial cuff is coupled to the left (a) and right atrial port (c). 
Four mechanical valves are also installed into left atrial port, 
aortic port, right atrial port, and pulmonary arterial port, 
respectively. Character “e” indicates the mechanical valve 
assembled to the right atrial port as an example. Locations of 
the right atrium, the left atrium, the aorta, and the pulmonary 
artery are similar to the natural hear as initially designed.
Fig. 7. A whole view of the assembled system. Character “a”, 
”b”, ”c” indicate blood pump, actuator, and controller and power 
supply, respectively. The blood pump is coupled with actuator 
with connecting wire and connector. The actuator is also 
hooked up to the controller and power supply via a shield line.
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2.2. Pump performance
　In the first evaluation aiming to evaluate initial 
performance of the whole system, strong twist of the 
connecting wire beyond expectation was obser ved 
under condition at afterload of over 100 mmHg. So 
the system was evaluated incapable to endure over 
100 mmHg of the afterload. Because of unpredicted 
weakness of the connecting system, the afterload was 
fixed at 80 mmHg for further evaluation including the 
second step. The maximum output of the left blood 
pump was 4.3 L/min under the condition of 20 mmHg of 
the preload and 70 mmHg of the afterload, and systemic 
efficiency was two percent.
　The second step of  evaluat ion using larger 
servomotor showed that the blood pump had enough 
potential performance for practical use. The left output 
increased gradually as the pump rate raised. The 
maximum output was 4.9 L/min at 95 RPM. Stroke 
volume was kept constant by 50ml(Fig. 9). The right 
output varied from4.3 L/min to 7.4 L/min, and its 
behavior was unstable. The stroke volume of the 
right output was not depending on pumping cycle and 
remained unstable (Fig. 10).
　The flow pattern of the left output showed flutter in 
the systolic phase. The flow trace was consisted of four 
small waves, which were considered being derived 
from four pairs of bearings. The right output showed 
smooth waveform like the natural heart output. Major 
regurgitation obser ved in the right waveform was 
supposed to be mainly produced by malfunction of the 
artificial valve (Fig. 11).
Fig. 9. Performance of the left pump in the second step of 
the study using DC actuator (100W, 24V). Stroke volume is 52 
ml. Calculated diaphragm displacement is 12mm. 
Fig. 8. The blood pump installed in the chest cavity model. 
AO: aortic port, LA: left atrial port, PA: pulmonary arterial 
port, RA: right atrial port, Lt: left chest cavity, Rt: right chest 
cavity, Anterior: Ventral side of the humane body, Posterior: 
Dorsal side of the humane body, V: Vertebra. 
Fig. 10. The changes of the left and the right stroke volumes 
by various pumping cycles in the second step of the study are 
drafted. While the left heart stroke volume (shown by closed 
square) remains stable, the right heart stroke volume (shown 
by closed circle) varies unstable.
Fig. 11. Traces of the left and right flow. Systolic duration 
per cycle is calculated 68％ during the measurement. Flutter 
phenomena is seen in the left output.
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3. Discussion
3.1. Generic requirements for TAH design and 
STAH
　Since Akutsu et al. reported the first successful 
experimental implantation of a total ar tificial heart 
(TAH) in 1958 1), various types of TAH have been 
developed. Only Liotta, Akutsu and Jarvik among the 
researchers made success in clinical application of their 
air driven devices2 -4). Especially Jarvik’s prosthesis 
has been widely accepted as the Cardiowest pump as 
a bridge to transplantation still now 10). But all these 
products require a big air - supply console outside of 
the human body. For further benefit to the patient, 
various trials have been made to implant whole system 
including the blood pump, driving unit, and battery 
system inside the human body 5 -10). Instead of long 
history of development, space availability of the human 
body has not allowed all these trials in successful 
application. Recently only the AbiCor pump has become 
successful to put all parts into a humane body in the 
experimental clinical trial11).
　The dif ficulty of designing artificial heart surely 
exists in space limitation of the human body. Compared 
to the natural heart that blood chamber wall which acts 
as a power unit as well as blood holding cell at the same 
time, the artificial heart must have two independent 
parts; the blood chamber and driving unit. It has been 
and still is hard to implant these two parts into humane 
pericardial space as one unit. In this study we solved 
this problem by departing the blood pump and driving 
unit. To introduce this concept, designing of the blood 
pump becomes easier and more flexible for anatomical 
fitting.
　Thrombus formation caused by activation of blood 
coagulation is another big problem for artificial heart 
as well as the anatomical property. But material and 
surface treatment to reduce thrombus formation in 
this study are considered little because fundamental 
mechanical property must be first object to be solved. 
This problem remains as a future settlement in the next 
stage of development. 
3.2. Anatomical suitability of the STAH
　Various studies have been done to estimate practical 
humane pericardial cavity in order to make a design of 
the artificial heart using magnetic resonance imaging 
or direct measurement of the human body performed 
in the consecutive orthotopic cardiac recipients 17 -20). 
According these results, the permissible space prepared 
for the artificial heart may stays in 10 cm sphere. The 
blood pump size of the STAH completely fulfilled this 
condition of the pericardial cavity. Practical trial using 
Uyama’s chest cavity model based on the magnetic 
resonance imaging proved suitability of the pump.  
　In this study we introduced a method to separate the 
artificial heart to the blood pump unit and the driving 
unit. This unique technique is also employed by the 
National Cardiovascular Center group9). The pump 
is driven by hydrodynamic actuator located in the 
abdominal cavity, and requires fairly big two conduits 
to flow the silicon oil tunneled through the diaphragm. 
Compared to their pump, the STAH is smaller in pump 
size and has a single thin cable against their two big oil 
conduits. 
　From the surgical point of view, distance between 
the left and right inlet is also an important factor. 
The previous total artificial hearts had wide distance 
between the left and right atrial port derived from 
mechanical construction. If it is possible to reduce the 
distance, implantation of the blood pump becomes 
easier. A unique design employed to the STAH that 
the two blood chambers are not placed in a parallel 
alignment, made possible to shorten the width between 
the left and right port. The design that is the first and 
only one technique ever used, except Helmholtz Total 
Artificial Heart15) appeared after the first presentation 
of the STAH in American Society of Artificial Internal 
Organs meeting in 1992. 
　Thus design of the STAH was proved to overcome 
some of the problems in anatomical suitability.
3.3. In vivo study
　In vivo study also proved potency of the STAH in 
practical performance. Due to energy loss, that means 
low mechanical efficiency, the small power unit used 
in the first step of evaluation could not ideally drive the 
system. The reason of low efficiency was apparently 
attributed to unsophisticated manufacture of the cam. 
But generic cam mechanism itself is already established 
in engineering field. It is surely not difficult to improve 
efficiency of the cam system adopted in the STAH. 
　According to Suga et al.21), requirement of the work 
to the natural heart to drive the systemic blood is said 
one to 10 W. So if system efficiency is improved up to 
10％, a conventional and commercially available DC 
servomotor just like employed in the STAH becomes 
a promising candidate for the system without major 
mechanical modification.
　In the experiment the reason why the right output 
was unstable and went over the expected volume by up 
to 50％ is unclear, while the left output remained within 
Hiroyuki Noda, et al 79Development of STAH
calculated range. One fact that outer shell of the blood 
pump was fabricated fairly soft and had some expansion 
characteristics, might af fect practical stroke of the 
right blood chamber. Another suspected reason may be 
instability of the diaphragm motion under low afterload 
condition. Since the soft silicon membrane suspends the 
diaphragm, the diaphragm must have swayed around 
the counter area of the cam tip. But these possibilities 
do not look fatal because the system itself is simple and 
easy enough for accepting further reinforcement of 
the chamber shell and improvement of manufacturing 
process.
　The flutter seen in the left flow may not be a fatal 
problem in a physiological point of view, because, as far 
as the output is maintained, the flow is going smoothen 
by compliance of the vessels. But of course this 
turbulence must be eliminated from engineering point, 
and it is easy when the cam system is improved. In the 
next stage of development the bearings will be taken 
out from the system by smoothing the cam and plate 
surface. 
　Regurgitation observed at the right pump flow was 
considered mainly due to the mechanical ar tificial 
valve employed in the prototype. The slight backflow is 
generally seen when the mechanical artificial valve is 
closed. As far as total performance is maintained, small 
back flow is not a major problem. If there exists some 
need to solve this problem, best answer is to adopt 
the biomechanical valve. But the high height of the 
biomechanical valve has refused to be incorporated into 
the total artificial heart ever.
　Confined air inside the pump might affect stability of 
the pump efficiency. The inside space of the STAH is 
airtight and not opened to the air. When the one side 
of the diaphragm moves, the air is expanded and the 
negative pressure is produced. The negative force pulls 
the other diaphragm and consequently sucks the blood 
into the blood chamber. Generally the air compliance 
chamber is adopted as another unit to stabilize the 
performance of a mechanical pump like Honda et al. 
reported8). Compared to their pump that has less loose 
cavity for the air because of mechanically tight design, 
the STAH has fairly big space for cam rotation. Thus 
the STAH resulted in elimination of the air - compliance 
chamber. 
3.4. Expected improvements in future
　We are planning to establish the next generation of 
the device. Improvement of the cam system must be the 
first target to raise system efficiency up. Some material, 
which has enough durability of fatigue strength, friction 
strength, and hard deformity, will be employed for 
cam plate and metal diaphragm plate. Bearings must 
be eliminated in order to give smooth motion of the 
diaphragm as well as to reduce structural friction. A 
metal plate - spring like moving arms will be applied 
to suspend the diaphragm plate to give steady motion 
and to eliminate flutter of the plate. For these trials, no 
new research is required because all of them have been 
already put into the practically industrial use.
　For the practical model, battery and transcutaneous 
power transmitting system will be also incorporated 
into the system. To accomplish the development, 
cooperative work with the other fields of engineering is 
necessary. The final plan of the STAH-1 is illustrated in 
Fig. 12, which includes these attachment devices. 
　Biological adaptation will  rise up as another 
factor to control the system. Looking back the past 
experiences, a role of the total/par tial ar tificial 
heart is just to push out the blood without positive 
biological neural feedback, only depending on volume 
of the venous return. The reason why such simple 
mechanism is acceptable in the actual situation is 
that, as far as minimum requirement of the systemic 
flow is maintained, the peripheral resistance changes 
Fig. 12. Outline of the final system of the STAH.
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automatically in order to supply optimum organ flow 
according to oxygen demand. If control of the pumping 
rate of the artificial heart becomes possible according 
to natural demand, the artificial heart will give further 
expansion of the social life activity to the patient. In the 
process of further improvement of the system, some 
method to detect natural feedback of the body must 
be introduced such as continuous measuring of mixed 
venous saturation22, 23). 
5. Conclusion
　A prototype of the ar tificial hear t(STAH) was 
developed aiming to be installed totally inside the 
human body. A simple cam system, and separation 
of the device into blood chamber and driving unit 
made the blood pump placed easily inside the natural 
pericardial cavity. Although further improvements must 
be required in the future, the STAH is a potential device 
for clinical applicatio
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